Skip to content
★ Sign in to follow
Total declarations
3
Company
1
▲ Purchases (3 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 03 Jul 2026 for 경남제약.

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

엑스: trading record in brief

엑스 is a declared insider of 경남제약, with filings sourced from DART (FSS). Activity is concentrated on a single trading day, 3 July 2026, with 3 filings.

Purchases make up the whole of the open-market record (3 purchases). The totals do not cover 3 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The record was last updated on 3 July 2026 with an open-market purchase in 경남제약. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Companies and markets linked to 엑스

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    대량보유자Executives(filed)경남제약
    0DART
    3,990,178 sharesKRXDART:20260703000540
    Canonical exit: 1 Oct 2026 (T+90)
  • ▲
    10%이상주주Executives(filed)경남제약
    0DART
    3,990,178 sharesShareKRXDART:20260703000512
    Canonical exit: 1 Oct 2026 (T+90)
  • ▲
    대량보유자Executives(filed)경남제약
    0DART
    3,990,178 sharesKRXDART:20260703000504
    Canonical exit: 1 Oct 2026 (T+90)

3 of 3 declarations